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Development of a Scalable Synthesis of
HP-β-CD Pluronic Polyrotaxanes
Student researchers: Joseph L. Skulsky, Senior,
and Elizabeth A. Slepko, Junior
Polyrotaxanes are polymers that have macrocycles threaded onto
them, analogous to beads threaded onto a string. These materials
are used for a variety of biomedical applications. The Thompson
Group has been developing 2-hydroxypropyl-β-cyclodextrin
(HP-β-CD) polyrotaxanes as therapeutics for the treatment of
Niemann-Pick Type C (NPC) disease, a debilitating genetic
disorder in which unesteriﬁed cholesterol accumulates in the
lysosomes of cells. Developing a scalable process is crucial for
the advancement of these materials as NPC therapeutics. The goal
of this project is to optimize a protocol for the synthesis of HPβ-CD/Pluronic polyrotaxanes in order to develop a method that
can be operated on the multi-gram scale to support preclinical
studies. Each component of the protocol was screened to determine
which combination led to the formation of polyrotaxanes with the
highest yields and threading efﬁciencies in the shortest amount
of time. Threading efﬁciency is a measure of how many HP-βCD molecules are threaded onto each polymer. Nuclear magnetic
resonance (NMR) spectroscopy suggested that probe sonication
and bath sonication are both necessary components of the optimal
protocol. This indicates that sufﬁcient agitation of the reaction
mixture is required to promote the non-covalent threading
reaction. Furthermore, bath sonication for one hour, followed
by stirring for two days, gave the highest threading efﬁciency.
The results of these studies have streamlined the existing protocol
for HP-β-CD and Pluronic F127 and for HP-β-CD and Pluronic
L81; however, additional studies are needed to reveal whether this
protocol is robust enough for efﬁcient preparation of other HP-βCD/Pluronic polyrotaxane derivatives.

Research advisor David H. Thompson writes: “The students
worked tirelessly in the David H. Thompson Lab in the Purdue
Department of Chemistry to prepare a family of ’wheel-and-axle’
type of polymers known as polyrotaxanes. These compounds are
of great interest because of their capacity to serve as cholesterolmobilizing molecules in Niemann-Pick Type C disease, as well
as potentially acting as long circulating MRI agents for tumor
detection. The students’ work has laid an important foundation for
us to pursue these applications by working out the details of their
efﬁcient synthesis.”

Synthesis of HP-β-CD/Pluronic polyrotaxanes with cholesterol
end-caps. The Pluronic triblock copolymer starting material is
modified so that cholesterol end-caps can be used to keep the
HP-β-CD molecules (blue structure) threaded. It was found that
stirring the Pluronic F127 and HP-β-CD for 48 hours afforded
the best threading efficiency, while highly threaded HPβ-CD/
L81 polyrotaxanes were obtained after just 1 hour of stirring.

Skulsky, J. L., & Slepko, E.A. (2016). Development of a scalable synthesis of HP-β-CD pluronic polyrotaxanes. Journal of Purdue
Undergraduate Research, 6, 94–95. http://dx.doi.org/10.5703/1288284316215

http://dx.doi.org/10.5703/1288284316215

